Xiaohang Cao Selected Research

Superoxide Dismutase

7/2010	Disrupted zinc-binding sites in structures of pathogenic SOD1 variants D124V and H80R.
4/2009	Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q.
6/2008	Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis.
12/2005	Proteasomal degradation of mutant superoxide dismutases linked to amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohang Cao Research Topics

Disease

5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2010 - 12/2005
4	Schistosomiasis (Bilharziasis) 01/2020 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2010 - 12/2005
2	Infections 01/2020 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 10/2018 - 01/2016
1	Hypoxia (Hypoxemia) 01/2012
1	Cholera 08/2011
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2007

Drug/Important Bio-Agent (IBA)

6	CopperIBA 01/2012 - 12/2005
4	ZincIBA 07/2010 - 12/2005
4	Superoxide DismutaseIBA 07/2010 - 12/2005
3	Oxamniquine FDA Link 10/2018 - 01/2016
2	Praziquantel (Biltricide)FDA Link 01/2020 - 10/2018
1	Drug CombinationsIBA 01/2020
1	HycanthoneIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2012
1	EnzymesIBA 01/2012
1	Serine (L-Serine)FDA Link 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2011
1	MetalsIBA 06/2008
1	DisulfidesIBA 06/2008
1	Superoxide Dismutase-1IBA 01/2007
1	LigandsIBA 01/2007
1	Superoxides (Superoxide)IBA 12/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2018
1	Therapeutics 01/2017